SEPN
SEPN
NASDAQ · Pharmaceuticals

Septerna Inc

$39.40
+0.86 (+2.23%)
As of Sep 22, 2:05 PM ET ·
Financial Highlights (FY 2026)
Revenue
49.25M
Net Income
-52,388,121
Gross Margin
Profit Margin
-106.4%
Rev Growth
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 51.4% 51.4% 51.4%
Operating Margin -148.6% 37.7% 41.6% 40.2%
Profit Margin -106.4% 30.9% 31.1% 30.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 49.25M 203.59M 209.55M 172.61M
Gross Profit 104.74M 107.80M 88.80M
Operating Income -73,197,109 76.67M 87.11M 69.31M
Net Income -52,388,121 62.98M 65.23M 53.09M
Gross Margin 51.4% 51.4% 51.4%
Operating Margin -148.6% 37.7% 41.6% 40.2%
Profit Margin -106.4% 30.9% 31.1% 30.8%
Rev Growth +1.5% +13.6% +0.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 152.75M 171.86M 171.94M
Total Equity 626.19M 687.13M 754.44M
D/E Ratio 0.24 0.25 0.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -71,481,040 113.38M 119.42M 97.18M
Free Cash Flow 53.53M 45.52M 42.56M